. Ingelheim and IBM have joined forces to use clinical recordkeeping in a clinical trial in Canada , using IBM ’s technology . They say they want to check whether a decentralised service can provide integrity and transparency in trials , automate some processes and cut costs . They also aim to make it easier for study participants to claim ownership over their data, and revoke or reauthorize their consent if necessary. The companies also want to make it easier for people taking part in trials to have control over their data . The trial will compare the system ’s performance with established methods . Boehringer is already developing blockchain for its supply operations but the project with IBM will be its first use of blockchain in clinical trials .
. Ingelheim and IBM have joined forces to use clinical recordkeeping in a clinical trial in Canada , using IBM ’s technology . They say they want to check whether a decentralised service can provide integrity and transparency in trials , automate some processes and cut costs . The companies also want to make it easier for people taking part in trials to have control over their data . The trial will compare the system ’s performance with established methods . Boehringer is already developing blockchain for its supply operations but the project with IBM will be its first use of blockchain in clinical trials .